# Ligand Pharmaceuticals Inc. (LGND) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $41M |
| 2024 | -$23M |
| 2023 | $12M |
| 2022 | $3M |
| 2021 | $104M |
| 2020 | $38M |
| 2019 | $807M |
| 2018 | $164M |
| 2017 | $68M |
| 2016 | $44M |
| 2015 | $27M |
| 2014 | $20M |
| 2013 | $15M |
| 2012 | $193,000 |
| 2011 | -$878,000 |
| 2010 | -$29M |
| 2009 | -$10M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | $17M |
| 2025-09-30 | $55M |
| 2025-06-30 | $8M |
| 2025-03-31 | -$36M |
| 2024-09-30 | $3M |
| 2024-06-30 | -$19M |
| 2024-03-31 | $3M |
| 2023-09-30 | $3M |
| 2023-06-30 | -$2M |
| 2023-03-31 | $14M |
| 2022-09-30 | $12M |
| 2022-06-30 | $9M |
| 2022-03-31 | $2M |
| 2021-09-30 | $16M |
| 2021-06-30 | $46M |
| 2021-03-31 | $5M |
| 2020-09-30 | $4M |
| 2020-06-30 | $7M |
| 2020-03-31 | $4M |
| 2019-09-30 | -$5M |
| 2019-06-30 | -$4M |
| 2019-03-31 | $827M |
| 2018-09-30 | $23M |
| 2018-06-30 | $70M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/LGND/operating-income)